Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: Pharmacogenetic Study in Patients Received Iron Chelating Agent
Brief Summary: To investigate effect of genetic variations on the toxicities and find optimal target population, the investigators planned to analyze the genetic polymorphisms of UDP-glucuronosyltransferase.